An overview of the newborn and infant physical examination screening end-to-end pathway. Category: UncategorisedBy 21 June 2021Leave a commentPost navigationPreviousPrevious post:Guidance: Sickle cell and thalassaemia screening pathway requirements specificationNextNext post:Research: Rubella: confirmed cases